Pediatric Cancer Biomarkers Market Size, Share, Trends, Growth Forecasts 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Pediatric Cancer Biomarkers Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-economic Factors
      1. Impact of Pediatric Oncology Infrastructure on Biomarker Testing Access
      2. Trends in Pediatric Cancer Diagnostic Funding: Public vs. Private Sector
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
4. Pricing and Reimbursement Analysis, 2024A
   1. Key Highlights
   2. Overview of Pediatric Biomarker Testing Costs
   3. Key Pediatric-specific Testing Cost Drivers
   4. Reimbursement Policies for Pediatric Cancer Biomarkers by Region
5. Global Pediatric Cancer Biomarkers Market Outlook
   1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Mn) and Y-o-Y Growth
      3. Absolute $ Opportunity
   2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2025 - 2032
   3. Global Pediatric Cancer Biomarkers Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Indication, 2019 - 2024
      3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Indication, 2025 - 2032
         1. Leukemia
         2. Neuroblastoma
         3. CNS Tumors
         4. Lymphoma
         5. Others
      4. Market Attractiveness Analysis: Indication
   4. Global Pediatric Cancer Biomarkers Market Outlook: Biomarker
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Biomarker, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025 - 2032
         1. Alpha-fetoprotein (AFP)
         2. Neuron-specific Enolase (NSE)
         3. CD19, CD20, CD22
         4. ALK (Anaplastic Lymphoma Kinase)
         5. Others
      4. Market Attractiveness Analysis: Biomarker
   5. Global Pediatric Cancer Biomarkers Market Outlook: End Use
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By End Use, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
         1. Hospital
         2. Diagnostic Laboratories
         3. Oncology Centers
         4. Research Institutions
      4. Market Attractiveness Analysis: End Use
6. Global Pediatric Cancer Biomarkers Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019 - 2024
   3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
7. North America Pediatric Cancer Biomarkers Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Indication
      3. By Biomarker
      4. By End Use
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Indication, 2025 - 2032
      1. Leukemia
      2. Neuroblastoma
      3. CNS Tumors
      4. Lymphoma
      5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025 - 2032
      1. 1. Alpha-fetoprotein (AFP)
         2. Neuron-specific Enolase (NSE)
         3. CD19, CD20, CD22
         4. ALK (Anaplastic Lymphoma Kinase)
         5. Others
      2. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
      1. Hospital
      2. Diagnostic Laboratories
      3. Oncology Centers
      4. Research Institutions
   7. Market Attractiveness Analysis
8. Europe Pediatric Cancer Biomarkers Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Indication
      3. By Biomarker
      4. By End Use
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Indication, 2025 - 2032
      1. Leukemia
      2. Neuroblastoma
      3. CNS Tumors
      4. Lymphoma
      5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025 - 2032
      1. Alpha-fetoprotein (AFP)
      2. Neuron-specific Enolase (NSE)
      3. CD19, CD20, CD22
      4. ALK (Anaplastic Lymphoma Kinase)
      5. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
      1. Hospital
      2. Diagnostic Laboratories
      3. Oncology Centers
      4. Research Institutions
   7. Market Attractiveness Analysis
9. East Asia Pediatric Cancer Biomarkers Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Indication
      3. By Biomarker
      4. By End Use
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Indication, 2025 - 2032
      1. Leukemia
      2. Neuroblastoma
      3. CNS Tumors
      4. Lymphoma
      5. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025 - 2032
      1. 1. 1. Alpha-fetoprotein (AFP)
            2. Neuron-specific Enolase (NSE)
            3. CD19, CD20, CD22
            4. ALK (Anaplastic Lymphoma Kinase)
            5. Others
         2. Biopsy
      2. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
      1. Hospital
      2. Diagnostic Laboratories
      3. Oncology Centers
      4. Research Institutions
   7. Market Attractiveness Analysis
10. South Asia & Oceania Pediatric Cancer Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Indication
       3. By Biomarker
       4. By End Use
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. India
       2. Southeast Asia
       3. ANZ
       4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Indication, 2025 - 2032
       1. Leukemia
       2. Neuroblastoma
       3. CNS Tumors
       4. Lymphoma
       5. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025 - 2032
       1. Alpha-fetoprotein (AFP)
       2. Neuron-specific Enolase (NSE)
       3. CD19, CD20, CD22
       4. ALK (Anaplastic Lymphoma Kinase)
       5. Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
       1. Hospital
       2. Diagnostic Laboratories
       3. Oncology Centers
       4. Research Institutions
    7. Market Attractiveness Analysis
11. Latin America Pediatric Cancer Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Indication
       3. By Biomarker
       4. By End Use
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Indication, 2025 - 2032
       1. Leukemia
       2. Neuroblastoma
       3. CNS Tumors
       4. Lymphoma
       5. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025 - 2032
       1. Alpha-fetoprotein (AFP)
       2. Neuron-specific Enolase (NSE)
       3. CD19, CD20, CD22
       4. ALK (Anaplastic Lymphoma Kinase)
       5. Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
       1. Hospital
       2. Diagnostic Laboratories
       3. Oncology Centers
       4. Research Institutions
    7. Market Attractiveness Analysis
12. Middle East & Africa Pediatric Cancer Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Indication
       3. By Biomarker
       4. By End Use
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Indication, 2025 - 2032
       1. Leukemia
       2. Neuroblastoma
       3. CNS Tumors
       4. Lymphoma
       5. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker, 2025 - 2032
       1. Alpha-fetoprotein (AFP)
       2. Neuron-specific Enolase (NSE)
       3. CD19, CD20, CD22
       4. ALK (Anaplastic Lymphoma Kinase)
       5. Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End Use, 2025 - 2032
       1. Hospital
       2. Diagnostic Laboratories
       3. Oncology Centers
       4. Research Institutions
    7. Market Attractiveness Analysis
13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. F. Hoffmann-La Roche Ltd
          1. Overview
          2. Segments and Indications
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Abbott
       3. QIAGEN
       4. Siemens Healthineers
       5. Thermo Fisher Scientific
       6. Beckman Coulter
       7. Myriad Genetics
       8. Agilent Technologies
       9. Bio-Rad Laboratories
       10. Randox Laboratories Ltd.
       11. BIOMÉRIEUX
       12. RayBiotech, Inc.
       13. Others
14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations